
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Intrinsic Value
The intrinsic value of one
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
stock under the Base Case scenario is
63.13
CNY.
Compared to the current market price of 65 CNY,
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is
Overvalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Balance Sheet Decomposition
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Current Assets | 9B |
Cash & Short-Term Investments | 4.9B |
Receivables | 2.5B |
Other Current Assets | 1.6B |
Non-Current Assets | 5.8B |
Long-Term Investments | 1.1B |
PP&E | 3.3B |
Intangibles | 685.7m |
Other Non-Current Assets | 669.6m |
Free Cash Flow Analysis
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Revenue
|
2.5B
CNY
|
Cost of Revenue
|
-771.7m
CNY
|
Gross Profit
|
1.7B
CNY
|
Operating Expenses
|
-2.3B
CNY
|
Operating Income
|
-544.9m
CNY
|
Other Expenses
|
250.8m
CNY
|
Net Income
|
-294m
CNY
|
Profitability Score
Profitability Due Diligence
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Score
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
According to Wall Street analysts, the average 1-year price target for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is 62.63 CNY
with a low forecast of 48.99 CNY and a high forecast of 78.02 CNY.
Dividends
Current shareholder yield for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
stock under the Base Case scenario is
63.13
CNY.
Compared to the current market price of 65 CNY,
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is
Overvalued by 3%.